Basic information Safety Supplier Related

METHYL 3-IODO-4-METHYLBENZOATE

Basic information Safety Supplier Related

METHYL 3-IODO-4-METHYLBENZOATE Basic information

Product Name:
METHYL 3-IODO-4-METHYLBENZOATE
Synonyms:
  • 3-IODO-4-METHYLBENZOIC ACID METHYL ESTER
  • METHYL 3-IODO-4-METHYLBENZOATE
  • METHYL 3-IODO-4-METH
  • 2-Iodo-4-(methoxycarbonyl)toluene, Methyl 3-iodo-p-toluate
  • Methyl3-Iodo-4-methylbenzoate>
  • 3-Iodo-4-methyL
  • Benzoic acid, 3-iodo-4-methyl-, methyl ester
  • 3-Iodo-p-toluic Acid Methyl Ester
CAS:
90347-66-3
MF:
C9H9IO2
MW:
276.07
Product Categories:
  • Benzenes
  • Aromatic Esters
  • Miscellaneous
  • Acids & Esters
  • Iodine Compounds
Mol File:
90347-66-3.mol
More
Less

METHYL 3-IODO-4-METHYLBENZOATE Chemical Properties

Boiling point:
302.9±30.0 °C(Predicted)
Density 
1.666±0.06 g/cm3(Predicted)
refractive index 
1.5975
storage temp. 
2-8°C(protect from light)
form 
powder to lump to clear liquid
color 
White or Colorless to Yellow
Water Solubility 
Not miscible or difficult to mix with water.
Sensitive 
Light Sensitive
InChI
InChI=1S/C9H9IO2/c1-6-3-4-7(5-8(6)10)9(11)12-2/h3-5H,1-2H3
InChIKey
NKMHAOTZPFVSPC-UHFFFAOYSA-N
SMILES
C(OC)(=O)C1=CC=C(C)C(I)=C1
More
Less

Safety Information

Hazard Codes 
Xi
Hazard Note 
Irritant
HS Code 
2916399090
More
Less

METHYL 3-IODO-4-METHYLBENZOATE Usage And Synthesis

Chemical Properties

White crystalline

Uses

Methyl 3-Iodo-4-methylbenzoate is used as a reagent in the synthesis of [(pyrazolo[1,5-a]pyridmidinyl)ethynyl]benzamides as selective discoidin domain receptor 1 (DDR1) inhibitors. Also used as a reagent in the preparation of orally bioavailable GZD824 targeting Breakpoint Cluster Region-Abelson (Bcr-Abl) kinase and overcoming antitumor drug resistance.

Synthesis

67-56-1

82998-57-0

90347-66-3

1. 3-iodo-4-methylbenzoic acid (28.0 g, 0.107 mol) was dissolved in methanol (300 mL) at 0 °C. 2. Concentrated sulfuric acid (30 mL) was added slowly to the above solution. 3. The reaction mixture was heated to 60 °C and kept reacting overnight. 4. When the reaction is complete, cool to room temperature and remove the solvent by distillation under reduced pressure. 5. The residue was carefully poured into ice water (200 mL) and extracted with ethyl acetate (500 mL). 6. The organic phase was washed sequentially with water (100 mL), saturated sodium bicarbonate solution (100 mL) and brine (100 mL). 7. The organic phase was dried over anhydrous magnesium sulfate, filtered and concentrated to afford the target product methyl 3-iodo-4-methylbenzoate as a brown oil (29.0 g, 98% yield). 8. The product was characterized by 1H NMR (400 MHz, CDCl3): δ8.47 (d, J=1.7 Hz, 1H), 7.90 (dd, J=7.9 Hz, 1.7 Hz, 1H), 7.29 (d, J=7.9 Hz, 1H), 3.90 (s, 3H), 2.48 (s, 3H).

References

[1] Collection of Czechoslovak Chemical Communications, 1999, vol. 64, # 4, p. 649 - 672
[2] Patent: WO2014/8197, 2014, A1. Location in patent: Page/Page column 71
[3] Patent: WO2015/95767, 2015, A1. Location in patent: Page/Page column 86
[4] Patent: EP2322176, 2011, A1. Location in patent: Page/Page column 21
[5] Patent: WO2011/57757, 2011, A1. Location in patent: Page/Page column 36-37

METHYL 3-IODO-4-METHYLBENZOATESupplier

ShangHai ZiCheng Med-Pharm Technology Company Ltd. Gold
Tel
021-56710790 18721468858
Email
wangyh@fudan.edu.cn
Shandong Xuanshuo Pharmaceutical Technology Co. LTD Gold
Tel
15269103900
Email
suchangzhou@shiningpharm.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com